Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-19 16:00 |
Compugen Reports First Quarter 2025 Results
|
English | 157.5 KB | ||
| 2025-05-19 16:00 |
Compugen Reports First Quarter 2025 Results
|
English | 36.2 KB | ||
| 2025-05-13 16:00 |
Leadership Transitions Effective September 2025
|
English | 484.4 KB | ||
| 2025-05-13 16:00 |
Leadership Transitions Effective September 2025
|
English | 36.3 KB | ||
| 2025-05-05 15:59 |
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025, confere…
|
English | 89.2 KB | ||
| 2025-05-05 15:59 |
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025, confere…
|
English | 36.3 KB | ||
| 2025-03-26 14:00 |
Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
|
English | 97.4 KB | ||
| 2025-03-26 14:00 |
Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
|
English | 36.3 KB | ||
| 2025-03-04 15:30 |
FORM 20-F- For the fiscal year ended December 31, 2024
|
English | 1.4 MB | ||
| 2025-03-04 15:30 |
FORM 20-F- For the fiscal year ended December 31, 2024
|
English | 36.4 KB | ||
| 2025-03-04 15:00 |
Form 6-K- Fourth Quarter and Full Year 2024 Results
|
English | 1.4 MB | ||
| 2025-03-04 15:00 |
Form 6-K- Fourth Quarter and Full Year 2024 Results
|
English | 36.4 KB | ||
| 2025-03-03 15:00 |
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global …
|
English | 94.1 KB | ||
| 2025-03-03 15:00 |
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global …
|
English | 36.3 KB | ||
| 2025-02-26 15:00 |
Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen…
|
English | 100.4 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
